Clinical Trial Update: Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of sublingual fentanyl tablets for breakthrough pain in cancer patients has completed. The update highlights …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Sublingual Fentanyl Tablets (fentanyl)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Pain, Cancer | Phase 3 | Status: COMPLETED